Oral delivery of tumor-targeting Salmonella exhibits promising therapeutic efficacy and low toxicity

Cancer Science

Volumn 100, Issue 12, 2009, Pages 2437-2443

  Chen, Guo ^a   Wei, Dong Ping ^a   Jia, Li Jun ^a   Tang, Bo ^a   Shu, Luan ^a   Zhang, Kui ^a   Xu, Yun ^a   Gao, Jing ^a   Huang, Xiao Feng ^b   Jiang, Wen Hui ^b   Hu, Qin Gang ^b   Huang, Yan ^a   Wu, Qiang ^c   Sun, Zhi Hua ^c   Zhang, Jian Fa ^d   Hua, Zi Chun ^a  

^a NANJING UNIVERSITY   (China)

^b Jiangsu Province Engineering Research Center of Stomatological Translational Medicine   (China)

^c JIANGSU CANCER HOSPITAL   (China)

^d NANJING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VNP 20004; VNP 20006; VNP 20009;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; FEMALE; GROWTH INHIBITION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LEWIS CARCINOMA; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SINGLE DRUG DOSE; TOXICITY TESTING; TREATMENT RESPONSE; TUMOR GROWTH;

ADMINISTRATION, ORAL; ANIMALS; BACTERIAL VACCINES; CYTOKINES; FEMALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; SALMONELLA TYPHIMURIUM;

EID: 70649083893     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01337.x     Document Type: Article

References (30)

1. Sznol M, Lin SL, Bermudes D, Zheng LM, King I. Use of preferentially replicating bacteria for the treatment of cancer. J Clin Invest 2000, 105:1027-30.
2. Pawelek JM, Low KB, Bermudes D. Bacteria as tumour-targeting vectors. Lancet Oncol 2003, 4:20-8.
3. Katsuhiro Hayashi, Zhao M, Kensuke Yamauchi. Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 2009, 106:992-8.
4. Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci 2007, 104:10170-4.
5. Zhao M, Yang M, Ma HY. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 2006, 66(15):7647-52.
6. Pawelek JM, Low KB, Bermudes D. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 1997, 57:4537-44.
7. Low KB, Ittensohn M, Le T. Mutant Salmonella with suppressed virulence and TNF-alpha induction retain tumor targeting in vivo. Nat Biotechnol 1999, 17:37-41.
8. Rosenberg SA, Spiess PJ, Kleiner DE. Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium. J Immunother 2002, 25:218-25.
9. Zhao M, Yang M, Li XM. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci 2005, 102:755-60.
10. Lee CH, Wu CL, Shiau AL. Salmonella choleraesuis as an anticancer agent in a syngeneic model of orthotopic hepatocellular carcinoma. Int J Cancer 2008, 122:930-5.
11. Zheng LM, Luo X, Feng M. Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector. Oncol Res 2000, 12:127-35.
12. Friedlos F, Lehouritis P, Ogilvie L. Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy. Clin Cancer Res 2008, 14(13):4259-66.
13. King I, Bermudes D, Lin S. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent. Hum Gene Ther 2002, 13:1225-33.
14. Lee CH, Wu CL, Shiau AL. Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model. Cancer Gene Ther 2005, 12:175-84.
15. Lee CH, Wu CL, Shiau AL. Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models. J Gene Med 2004, 6:1382-93.
16. Platt J, Sodi S, Kelley M. Antitumor effect of genetically engineered Salmonella in combination with radiation. Eur J Cancer 2000, 36:2397-402.
17. Jia LJ, Xu HM, Ma DY. Enhanced therapeutic effect by combination of tumor targeting Salmonella and endostatin in murine melanoma model. Cancer Bio Ther 2005, 4:840-5.
18. Jia LJ, Wei DP, Sun QM. Tumor-targeting Salmonella typhimurium improves cyclophosphamide chemotherapy at maximum tolerated dose and low-dose metronomic regimens in a murine melanoma model. Int J Cancer 2007, 121:666-74.
19. Bettegowda C, Dang LH, Abrams R. Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proc Natl Acad Sci 2003, 100:15083-8.
20. Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B. Combination bacteriolytic therapy for the treatment of experimental tumor. Proc Natl Acad Sci 2001, 98:15155-60.
21. Dang LH, Bettegowda C, Agrawal N. Targeting vascular and a vascular compartment of tumor with C.novyi-NT and anti-microtubule agents. Cancer Bio Ther 2004, 3:326-37.
22. Lee CH, Wu CL, Tai YS, Shiau AL. Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy. Mol Ther 2005, 11:707-16.
23. Jia LJ, Wei DP, Sun QM, Huang Y, Wu Q, Hua ZC. Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor models. Cancer Sci 2007, 98:1107-12.
24. Low KB, Ittensohn M, Luo X. Construction of VNP20009: a novel genetically stable antibiotic sensitive strain of tumor targeting Salmonella for parenteral administration in humans. Methods Mol Med 2004, 90:47-60.
25. Clairmout C, Lee KC, Pike J. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis 2000, 181:1996-2002.
26. Baumler AJ, Tsolis RM, Heffron F, Wray C, Wray A. Virulence mechanisms of Salmonella and their genetic basis. Salmonella in Domestic Animals 2000, 57-72. In, eds, Wallingford, UK, CAB International
27. Carter PB, Collins FM. The route of enteric infection in normal mice. J Exp Med 1974, 139:1189-203.
28. Hiroyoshi Nishikawa, Eiichi Sato, Gabriel Briones. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J Clin Invest 2006, 116:1946-55.
29. Loessner H, Weiss S. Bacteria mediated DNA transfer in gene therapy and vaccination. Expert Opin Biol Ther 2004, 4:157-68.
30. Lee CH, Wu CL, Chen SH, Shiau AL. Humoral immune responses inhibit the antitumor activities mediated by Salmonella enterica Serovar choleraesuis. J Immunother 2009, 32:376-88.